Saba Capital Management, L.P. sold HQL

September 17, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 24,328 shares of Abrdn Life Sciences Investors at $13.99 per share, a transaction worth $340.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.